SynthesisFrontiers in urology2026
'Efficacy and safety outcomes after slings or artificial urinary sphincter implantation for non-neurogenic male stress urinary incontinence: a systematic review' for more clarity.
Synthesis in Frontiers in urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Our objective was to conduct a systematic review of studies comparing male slings (MS) and Artificial Urinary Sphincter (AUS) in terms of efficacy and safety in men with Stress Urinary Incontinence (SUI). Methods: We conducted a systematic review including all studies comparing MS and AUS in adult men with SUI. All synthetic MS were included. The primary outcome was the postoperative continence rate defined as either no pad use or one safety pad. Results: Of 133 references screened, after exclusion of duplicates, 18 papers were eligible for a full-text analysis and 9 studies (5921 patients) were included in the qualitative synthesis. Among these, one was a randomized controlled trial and eight were cohort studies. The cure rate varied from 14% to 94% for the AUS and 11% to 69% for the MS. Of the five studies reported both devices, two (40%) reported a continence rate above 70% for AUS. Eight of the nine studies (88.9%) reported safety outcomes. Urethral erosion was less frequent after male slings than after artificial urinary sphincter implantation, whereas urinary retention was more frequent after male slings in most studies. Conclusion: In comparative studies, continence proportions were generally higher after artificial urinary sphincter implantation, while the complication profiles of the two devices differ, with more erosion after the sphincter and more urinary retention after the sling. Confidence in these findings is limited by clinical heterogeneity, confounding by indication and inconsistent outcome definitions. Standardised outcome reporting and randomised data are needed. Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42024539539.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.